Incidental Mutation 'R0981:Irf1'
ID 97189
Institutional Source Beutler Lab
Gene Symbol Irf1
Ensembl Gene ENSMUSG00000018899
Gene Name interferon regulatory factor 1
Synonyms Irf-1
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R0981 (G1)
Quality Score 225
Status Not validated
Chromosome 11
Chromosomal Location 53660841-53669200 bp(+) (GRCm39)
Type of Mutation makesense
DNA Base Change (assembly) T to C at 53664548 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Stop codon to Arginine at position 52 (*52R)
Ref Sequence ENSEMBL: ENSMUSP00000118795 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000019043] [ENSMUST00000108920] [ENSMUST00000108922] [ENSMUST00000123376] [ENSMUST00000133291] [ENSMUST00000138913] [ENSMUST00000140866] [ENSMUST00000142221] [ENSMUST00000170390]
AlphaFold P15314
Predicted Effect probably damaging
Transcript: ENSMUST00000019043
AA Change: M85T

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000019043
Gene: ENSMUSG00000018899
AA Change: M85T

DomainStartEndE-ValueType
IRF 1 114 6.75e-62 SMART
low complexity region 120 138 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000108920
AA Change: M85T

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000104548
Gene: ENSMUSG00000018899
AA Change: M85T

DomainStartEndE-ValueType
IRF 1 114 6.75e-62 SMART
low complexity region 120 138 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000108922
AA Change: M85T

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000104550
Gene: ENSMUSG00000018899
AA Change: M85T

DomainStartEndE-ValueType
IRF 1 114 6.75e-62 SMART
low complexity region 120 138 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000123376
AA Change: M85T

PolyPhen 2 Score 0.995 (Sensitivity: 0.68; Specificity: 0.97)
SMART Domains Protein: ENSMUSP00000122101
Gene: ENSMUSG00000018899
AA Change: M85T

DomainStartEndE-ValueType
IRF 1 114 6.75e-62 SMART
low complexity region 120 138 N/A INTRINSIC
Predicted Effect noncoding transcript
Transcript: ENSMUST00000128336
Predicted Effect probably damaging
Transcript: ENSMUST00000133291
AA Change: M85T

PolyPhen 2 Score 0.980 (Sensitivity: 0.75; Specificity: 0.96)
SMART Domains Protein: ENSMUSP00000116656
Gene: ENSMUSG00000018899
AA Change: M85T

DomainStartEndE-ValueType
IRF 1 114 6.75e-62 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000138913
SMART Domains Protein: ENSMUSP00000118314
Gene: ENSMUSG00000018899

DomainStartEndE-ValueType
IRF 1 62 2.41e-8 SMART
Predicted Effect probably damaging
Transcript: ENSMUST00000140866
AA Change: M85T

PolyPhen 2 Score 0.995 (Sensitivity: 0.68; Specificity: 0.97)
SMART Domains Protein: ENSMUSP00000114315
Gene: ENSMUSG00000018899
AA Change: M85T

DomainStartEndE-ValueType
IRF 1 114 6.75e-62 SMART
low complexity region 120 138 N/A INTRINSIC
Predicted Effect probably null
Transcript: ENSMUST00000142221
AA Change: *52R
SMART Domains Protein: ENSMUSP00000118795
Gene: ENSMUSG00000018899
AA Change: *52R

DomainStartEndE-ValueType
Pfam:IRF 5 48 4.8e-11 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000153054
Predicted Effect probably benign
Transcript: ENSMUST00000170390
Coding Region Coverage
  • 1x: 99.5%
  • 3x: 98.4%
  • 10x: 95.4%
  • 20x: 89.6%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] IRF1 encodes interferon regulatory factor 1, a member of the interferon regulatory transcription factor (IRF) family. IRF1 serves as an activator of interferons alpha and beta transcription, and in mouse it has been shown to be required for double-stranded RNA induction of these genes. IRF1 also functions as a transcription activator of genes induced by interferons alpha, beta, and gamma. Further, IRF1 has been shown to play roles in regulating apoptosis and tumor-suppressoion. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous disruption of this gene leads to reduced CD8+ T cell number and altered response to viral infection and may cause alterations in cytokine levels, CD4+ cell subset homeostasis, blood vessel healing, DNA repair, and susceptibility to induced lymphomas, arthritis and autoimmune encephalitis. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 42 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Aars2 T A 17: 45,831,257 (GRCm39) C942S probably damaging Het
Alpk1 T C 3: 127,473,051 (GRCm39) N984S possibly damaging Het
Ankrd55 T C 13: 112,459,610 (GRCm39) V68A possibly damaging Het
Asap2 T C 12: 21,315,961 (GRCm39) S960P probably damaging Het
Atp2b1 T A 10: 98,851,491 (GRCm39) N66K probably damaging Het
Cckar C T 5: 53,863,632 (GRCm39) G39R probably damaging Het
Cimap1a A G 7: 140,428,208 (GRCm39) M7V probably benign Het
Col11a1 G A 3: 113,932,414 (GRCm39) R113H unknown Het
Cpb1 C A 3: 20,329,654 (GRCm39) R24L probably benign Het
Dlg5 T G 14: 24,204,699 (GRCm39) R1258S probably damaging Het
Fanci A G 7: 79,054,914 (GRCm39) Q148R probably benign Het
Fcgbp T A 7: 27,784,535 (GRCm39) Y198* probably null Het
Gapt G C 13: 110,490,273 (GRCm39) T130R probably damaging Het
Garin5b T A 7: 4,760,588 (GRCm39) probably null Het
Glis1 A G 4: 107,472,239 (GRCm39) E272G probably damaging Het
Gm13741 T C 2: 87,486,578 (GRCm39) N229S probably benign Het
Gsdmc4 T A 15: 63,763,922 (GRCm39) I392F probably damaging Het
H2-M2 T C 17: 37,793,521 (GRCm39) T162A probably benign Het
Hk2 G A 6: 82,720,949 (GRCm39) R190W probably damaging Het
Lman2l T A 1: 36,484,314 (GRCm39) M1L unknown Het
Mgat1 C T 11: 49,151,882 (GRCm39) R122C probably damaging Het
Mtrf1 T C 14: 79,639,030 (GRCm39) L54S probably benign Het
Myo5c A T 9: 75,178,873 (GRCm39) L676F probably damaging Het
Ofcc1 A G 13: 40,226,174 (GRCm39) I786T probably damaging Het
Or5p64 AGGT A 7: 107,855,228 (GRCm39) probably benign Het
Or5p64 GGTAG GG 7: 107,855,229 (GRCm39) probably benign Het
Pfn1 G A 11: 70,542,964 (GRCm39) R137C probably benign Het
Pgbd5 G A 8: 125,111,032 (GRCm39) R129* probably null Het
Pibf1 T C 14: 99,388,179 (GRCm39) probably null Het
Pkd2l1 A G 19: 44,142,861 (GRCm39) probably null Het
Plin5 C A 17: 56,421,020 (GRCm39) R215L probably damaging Het
Prrc2c C T 1: 162,533,550 (GRCm39) probably benign Het
Rnasel T G 1: 153,635,345 (GRCm39) C608G probably benign Het
Slc28a2 T A 2: 122,281,465 (GRCm39) V218D probably damaging Het
Snx1 T C 9: 66,016,841 (GRCm39) I29V probably benign Het
Tenm3 A G 8: 48,752,000 (GRCm39) W939R probably damaging Het
Tmem237 C A 1: 59,157,164 (GRCm39) R15L probably damaging Het
Tmx3 T C 18: 90,555,324 (GRCm39) V347A probably benign Het
Vmn1r191 T C 13: 22,363,389 (GRCm39) T122A probably benign Het
Wdfy4 G T 14: 32,869,049 (GRCm39) N326K probably benign Het
Zfp408 A G 2: 91,475,528 (GRCm39) L642P probably benign Het
Zfp808 C A 13: 62,319,487 (GRCm39) H239N possibly damaging Het
Other mutations in Irf1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01355:Irf1 APN 11 53,665,187 (GRCm39) missense probably benign
IGL01743:Irf1 APN 11 53,665,277 (GRCm39) missense probably benign 0.39
endeka UTSW 11 53,663,717 (GRCm39) missense probably damaging 1.00
Endeka2 UTSW 11 53,662,148 (GRCm39) missense probably damaging 1.00
Longs_peak UTSW 11 53,666,762 (GRCm39) missense probably benign 0.27
R1861:Irf1 UTSW 11 53,665,183 (GRCm39) missense possibly damaging 0.65
R2511:Irf1 UTSW 11 53,664,617 (GRCm39) missense probably damaging 1.00
R5828:Irf1 UTSW 11 53,666,762 (GRCm39) missense probably benign 0.27
R6514:Irf1 UTSW 11 53,662,148 (GRCm39) missense probably damaging 1.00
R6986:Irf1 UTSW 11 53,664,966 (GRCm39) missense probably damaging 1.00
R7108:Irf1 UTSW 11 53,665,238 (GRCm39) missense probably damaging 1.00
R7696:Irf1 UTSW 11 53,667,162 (GRCm39) missense probably benign 0.07
R9055:Irf1 UTSW 11 53,667,196 (GRCm39) missense probably benign
Predicted Primers PCR Primer
(F):5'- GAGCCCATTTGAGTCCTTCACAGTC -3'
(R):5'- GCTGAGTCCATCAGAGAAAGTGTCC -3'

Sequencing Primer
(F):5'- GGATGTCTAAGCCAACTCTGG -3'
(R):5'- ACTTTCTCTCTGTGGGAAGAAC -3'
Posted On 2014-01-05